Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
In the pivotal STEP 1 trial, adults lost an average of 14.9% of their body weight over 68 weeks, versus 2.4% with placebo, and roughly half achieved 15% or more weight loss
were Lilly employees This study is registered with ClinicalTrials.gov, NCT04657016
The goal is not just losing weight
6.2 Modulation of gut microbiota Recent research suggests that GLP-1 receptor agonists significantly affect the composition of gut microbiota, revealing a new mechanism that contributes to metabolic advantages (Liang et al
The resulting G values, reflecting the impact of the pAcF mutation on binding affinity, were derived from the average output of a generalized additive model, based on 35 independent runs of the protocol
US$ 28.06
US$ 25.04
US$ 23.91
US$ 23.43
US$ 23.26
US$ 20.44
